McKesson
Login/Apply  

Login to SupplyManager

Login   Forgot user name or password?

Not Registered?

Request a Business Account   Contact us
mckesson
Login/Apply  

Login to SupplyManager

Login   Forgot user name or password?

Not Registered?

Request a Business Account   Contact us
SupplyManager℠  Help

Contact Us

Call Us

Customer Service 855.571.2100

Need help with SupplyManager?
800.422.0280

Accounts Receivable
800.453.5180

Other Online Resources

Tax Forms

SupplyManager Training

Send Us a Message

Account:

  1. Shop Medical Supplies & Equipment

Shop Amgen Inc, Secondary Hyperparathyroidism (HPT) Treatment, Injection

  • Amgen Inc
  • Secondary Hyperparathyroidism (HPT) Treatment
  • Injection
  • Clear All
  • All Products (2)
  • Brand or Series
    • Parsabiv® (2)
  • Type
    • Intravenous (2)
  • Volume
    • 0.5 mL (1)
    • 2 mL (1)
  • Strength
    • 10 mg / 2 mL (1)
    • 2.5 mg / 0.5 mL (1)
  • Generic Drug Name
    • Etelcalcetide (2)
  • Country of Origin
  • Trade Agreement Act (TAA) Compliant
  • Buy American Act (BAA) Compliant
(0)
    • Select Items to see more options
    • Compare Items
  • Compare
  • Sort by Best Match
    • Best Match
    • Most Popular
    • Product Name A to Z
    • Product Name Z to A
    • McKesson Item #
    • Manufacturer Item #
    • Manufacturer Name
  • Display 10
    • 10
    • 25
    • 50
    • 75
    • 100
No
Image
Compare
    ,for, Item ID-
  • #1286274
  • Amgen Inc #55513074220
Parsabiv® Etelcalcetide 10 mg / 2 mL Injection 2 mL
Log in for pricing and availability
  Log In to Order  View Alternatives
No
Image
Compare
    ,for, Item ID-
  • #1286637
  • Amgen Inc #55513074020
Parsabiv® Etelcalcetide 2.5 mg / 0.5 mL Injection 0.5 mL
Log in for pricing and availability
  Log In to Order  View Alternatives

  • Add up to 6 more items
Compare Products (0) Clear Compare
McKesson logo above business, care, connectivity logo

Medical Professionals
855.571.2100

Help Desk
800.422.0280

Accounts Receivable
800.453.5180


© 2026 McKesson Medical-Surgical Inc.